Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Ines Figueiredo"'
Autor:
Ricardo Donners, Ines Figueiredo, Daniel Westaby, Dow-Mu Koh, Nina Tunariu, Suzanne Carreira, Johann S. de Bono, Nicos Fotiadis
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Bone biopsies in metastatic castrate-resistant prostate cancer (mCRPC) patients can be challenging. This study’s objective was to prospectively validate a multiparametric bone MRI (mpBMRI) algorithm to facilitate target lesion s
Externí odkaz:
https://doaj.org/article/76c557085ee14e639a41f169264874dd
Autor:
Rafael Grochot, Suzanne Carreira, Susana Miranda, Ines Figueiredo, Claudia Bertan, Jan Rekowski, Wei Yuan, Ana Ferreira, Ruth Riisnaes, Antje Neeb, Bora Gurel, Maria de Los Dolores Fenor de la Maza, Christina Guo, Juliet Carmichael, Daniel Westaby, Joaquin Mateo, Adam Sharp, Terri P. McVeigh, Johann De Bono
Publikováno v:
European Urology Open Science, Vol 52, Iss , Pp 72-78 (2023)
Background: Germline mutations in the ataxia telangiectasia mutated (ATM) gene occur in 0.5–1% of the overall population and are associated with tumour predisposition. The clinical and pathological features of ATM-mutated prostate cancer (PC) are p
Externí odkaz:
https://doaj.org/article/eac68c6ede4f43d4a8673b793f11158f
Autor:
Wei Yuan, Mateus Crespo, Bora Gurel, Ines Figueiredo, Ruth Riisnaes, Ana Ferreira, Suzanne Carreira, Johann De Bono, Christina Guo, George Seed
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7a5a15b1f157498298af0dc804af70ab
Autor:
Johann S. deBono, Jeffrey R. Harris, Saskia M. Burm, Adriaan Vanderstichele, Mischa A. Houtkamp, Saida Aarass, Ruth Riisnaes, Ines Figueiredo, Daniel Nava Rodrigues, Rossitza Christova, Siel Olbrecht, Hans W. M. Niessen, Sigrid R. Ruuls, Danita H. Schuurhuis, Jeroen J. Lammerts van Bueren, Esther C. W. Breij, Ignace Vergote
Publikováno v:
Cancer Reports, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Background Elevated tissue factor (TF) expression, although restricted in normal tissue, has been reported in multiple solid cancers, and expression has been associated with poor prognosis. This manuscript compares TF expression across vario
Externí odkaz:
https://doaj.org/article/0e98ad51ac3645c9bafd82abf01d3681
Autor:
Robert Brown, Christina Yap, Johann De Bono, Malaka Ameratunga, Anna Minchom, Wei Yuan, Mateus Crespo, Bora Gurel, Ines Figueiredo, Susana Miranda, Ruth Riisnaes, Ana Ferreira, Claudia Bertan, Rita Pereira, Chloe Baker, Nina Tunariu, Suzanne Carreira, Udai Banerji, Juanita Lopez, Alison Turner, Wentin Chen, Abhijit Pal, Dionysis Papadatos-Pastos, Toby Prout, Maxime Chénard-Poirier, Andra Curcean, Nahal Masrour, Ricardo Morilla, Ben Jenkins, Anna Zachariou, Mona Parmar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/b9a84246b2264ed1b2c2acbbf2f19d79
Autor:
Andrea Biondo, Abhijit Pal, Ruth Riisnaes, Rajiv Shinde, Crescens Tiu, Fran Lockie, Chloe Baker, Claudia Bertan, Mateus Crespo, Ana Ferreira, Rita Pereira, Ines Figueiredo, Susana Miranda, Bora Gurel, Suzanne Carreira, Udai Banerji, Johann de Bono, Juanita Lopez, Nina Tunariu, Anna Minchom
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100309- (2021)
ABSTRACT: Early-phase cancer clinical trials are becoming increasingly accessible for patients with advanced cancer who have exhausted standard treatment options and later phase trial options. Many of these trials mandate research tissue biopsies. Re
Externí odkaz:
https://doaj.org/article/7ee213af1fdd4bdb8f1be7e81291035f
Autor:
Nicos Fotiadis, Anna Minchom, Mateus Crespo, Bora Gurel, Ines Figueiredo, Susana Miranda, Ruth Riisnaes, Ana Ferreira, Claudia Bertan, Rita Pereira, Matt Clarke, Chloe Baker, Joo Ern Ang, Nina Tunariu, Suzanne Carreira, Mary O'Brien, Udai Banerji, Juanita Lopez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundThis case represents an exceptional response to pembrolizumab in a patient with epithelioid mesothelioma with a further response on rechallenge.Case presentationA 77-year-old woman with advanced epithelioid mesothelioma extensively pretreat
Externí odkaz:
https://doaj.org/article/7e62949f48524365b46f3e0bf7017a58
Publikováno v:
Journal of Human Resource Management, Vol 19, Iss 2, Pp 18-30 (2016)
Applicant’s attraction in recruitment is perhaps one of the best known areas that integrate knowledge from different fields of research, such as the HRM, Communication and Work and Organizational Psychology. Under this thematic, the social networks
Externí odkaz:
https://doaj.org/article/20f913f150bd415d935652b3151319d3
Autor:
Laura Cato, Antje Neeb, Adam Sharp, Victor Buzón, Scott B Ficarro, Linxiao Yang, Claudia Muhle-Goll, Nane C Kuznik, Ruth Riisnaes, Daniel Nava Rodrigues, Olivier Armant, Victor Gourain, Guillaume Adelmant, Emmanuel A Ntim, Thomas Westerling, David Dolling, Pasquale Rescigno, Ines Figueiredo, Friedrich Fauser, Jennifer Wu, Jaice T Rottenberg, Liubov Shatkina, Claudia Ester, Burkhard Luy, Holger Puchta, Jakob Troppmair, Nicole Jung, Stefan Bräse, Uwe Strähle, Jarrod A Marto, Gerd Ulrich Nienhaus, Bissan Al-Lazikani, Xavier Salvatella, Johann S de Bono, Andrew CB Cato, Myles Brown
Publikováno v:
eLife, Vol 6 (2017)
Targeting the activation function-1 (AF-1) domain located in the N-terminus of the androgen receptor (AR) is an attractive therapeutic alternative to the current approaches to inhibit AR action in prostate cancer (PCa). Here we show that the AR AF-1
Externí odkaz:
https://doaj.org/article/067bbc10110344e49721dcddfaabbd03
Autor:
María Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, Irene M. Shui, Bora Gurel, Emily Cross, Suzanne Carreira, Wei Yuan, Daniel Westaby, Susana Miranda, Ana Ferreira, George Seed, Mateus Crespo, Ines Figueiredo, Claudia Bertan, Veronica Gil, Ruth Riisnaes, Adam Sharp, Daniel Nava Rodrigues, Pasquale Rescigno, Nina Tunariu, Xiao Qiao Liu, Razvan Cristescu, Charles Schloss, Christina Yap, Johann S. de Bono
Publikováno v:
European Urology Oncology. 5:659-667
Metastatic castration-resistant prostate cancer (mCRPC) is a heterogeneous disease in which molecular stratification is needed to improve clinical outcomes. The identification of predictive biomarkers can have a major impact on the care of these pati